Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Amortization of Deferred Charges (2016 - 2019)

STRATA Skin Sciences' Amortization of Deferred Charges history spans 8 years, with the latest figure at -$79000.0 for Q2 2020.

  • For Q2 2020, Amortization of Deferred Charges fell 119.44% year-over-year to -$79000.0; the TTM value through Sep 2020 reached $254000.0, up 1793.33%, while the annual FY2019 figure was $318000.0, N/A changed from the prior year.
  • Amortization of Deferred Charges for Q2 2020 was -$79000.0 at STRATA Skin Sciences, down from $79000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $254000.0 in Q4 2019 and bottomed at -$79000.0 in Q4 2018.
  • The 5-year median for Amortization of Deferred Charges is $54000.0 (2016), against an average of $44125.0.
  • The largest annual shift saw Amortization of Deferred Charges tumbled 564.71% in 2018 before it skyrocketed 421.52% in 2019.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $55000.0 in 2016, then crashed by 69.09% to $17000.0 in 2017, then crashed by 564.71% to -$79000.0 in 2018, then surged by 421.52% to $254000.0 in 2019, then tumbled by 131.1% to -$79000.0 in 2020.
  • Per Business Quant, the three most recent readings for SSKN's Amortization of Deferred Charges are -$79000.0 (Q2 2020), $79000.0 (Q1 2020), and $254000.0 (Q4 2019).